InMode Ltd. is rated a Buy, offering strong growth, innovation, global expansion, and attractive value. Learn more about INMD ...
YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...
Canaccord raised the firm’s price target on InMode (INMD) to $16 from $14 and keeps a Hold rating on the shares. The firm noted the announced preliminary Q3/25 results with revenues above estimates ...
InMode (INMD) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.34 per share a year ago. These figures are ...
IT white papers, webcasts, case studies, and much more - all free to registered TechRepublic members. Use this Linux guide to get your processes running smoothly again. Constantly Updated — The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results